狂野欧美激情性xxxx欧美I 成人性生交大片免费看中文网站I 日韩视频一区二区在线I 国产中的精品av小宝探花I 黄色国产在线I 久久精品视频在线观看I 在线天堂8√

熱門搜索:A549    293T 金黃色葡萄球菌 大腸桿菌 AKK菌
購物車 1 種商品 - 共0元
當前位置: 首頁 > ATCC代理 > 650E2-2B12, CMCC #10121 (IVI 10083)
最近瀏覽歷史
聯系我們
  • 0574-87157013
  • mingzhoubio@163.com
  • 浙江省寧波市鎮海區莊市街道興莊路9號
  • 創e慧谷42號樓B幢401室
650E2-2B12, CMCC #10121 (IVI 10083)
650E2-2B12, CMCC #10121 (IVI 10083)
規格:
貨期:
編號:B163802
品牌:Mingzhoubio

標準菌株
定量菌液
DNA
RNA

規格:
凍干粉
斜面
甘油
平板


產品名稱 650E2-2B12, CMCC #10121 (IVI 10083)
商品貨號 B163802
Organism Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma)
Tissue spleen
Cell Type hybridoma: B lymphocyte; somatic cell hybri
Product Format frozen
Morphology lymphoblast
Culture Properties suspension
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Age adult
Strain BALB/c
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Tumorigenic Yes
Effects
Yes, BALB/c and (C57BL/6 X BALB/c)F1 mice
Complete Growth Medium
Depositor's culture medium: Modified MA plus 10% fetal bovine serum.
Culture Conditions
Temperature: 37.0°C
Isotype IgG1
Name of Depositor Cetus Corp.
U.S. Patent Number
References

Ring DB, et al. Monoclonal anti-human breast cancer antibodies. US Patent 5,629,197 dated May 13 1997

Ring DB. Antigen-binding sites of antibody molecules specific for cancer antigens. US Patent 6,054,561 dated Apr 25 2000

梅經理 17280875617 1438578920
胡經理 13345964880 2438244627
周經理 17757487661 1296385441
于經理 18067160830 2088210172
沈經理 19548299266 2662369050
李經理 13626845108 972239479
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |